Ward C L, Omura S, Kopito R R
Department of Biological Sciences, Stanford University, California 94305-5020, USA.
Cell. 1995 Oct 6;83(1):121-7. doi: 10.1016/0092-8674(95)90240-6.
Most cases of cystic fibrosis are caused by mutations that interfere with the biosynthetic folding of the cystic fibrosis transmembrane conductance regulator (CFTR), leading to the rapid degradation of CFTR molecules that have not matured beyond the endoplasmic reticulum (ER). The mechanism by which integral membrane proteins including CFTR are recognized and targeted for ER degradation and the proteolytic machinery involved in this process are not well understood. We show here that the degradation of both wild-type and mutant CFTR is inhibited by two potent proteasome inhibitors that induce the accumulation of polyubiquitinated forms of immature CFTR. CFTR degradation was also inhibited by coexpression of a dominant negative ubiquitin mutant and in cells bearing a temperature-sensitive mutation in the ubiquitin-activating enzyme, confirming that ubiquitination is required for rapid CFTR degradation.
大多数囊性纤维化病例是由干扰囊性纤维化跨膜传导调节因子(CFTR)生物合成折叠的突变引起的,导致未在内质网(ER)之外成熟的CFTR分子迅速降解。包括CFTR在内的整合膜蛋白被识别并靶向内质网降解的机制以及参与该过程的蛋白水解机制尚未完全了解。我们在此表明,两种有效的蛋白酶体抑制剂可抑制野生型和突变型CFTR的降解,这两种抑制剂会诱导未成熟CFTR多聚泛素化形式的积累。共表达显性负性泛素突变体以及在泛素激活酶中存在温度敏感突变的细胞中,CFTR降解也受到抑制,这证实泛素化是CFTR快速降解所必需的。